Home/Microbiotica/Claire Birrell
CB

Claire Birrell

VP of Clinical Development

Microbiotica

Microbiotica Pipeline

DrugIndicationPhase
MB097Advanced Melanoma (co-therapy with immune checkpoint inhibitors)Phase 1b
MB310Ulcerative ColitisPhase 1b